In the BioHarmony Drug Report Database
Requip, Requip Xl (ropinirole) is a small molecule pharmaceutical. Ropinirole was first approved as Requip on 1997-09-19. It is used to treat parkinson disease in the USA. The pharmaceutical is active against D(2) dopamine receptor and D(3) dopamine receptor. Requip’s patents are valid until 2021-12-02 (FDA).
Image (chem structure or protein)